The new training ground built to match Bournemouth’s ambition

Kelly Somers meets Bournemouth head coach Andoni Iraola and fomer captain Simon Francis, now first-team technical director, for a tour of the Cherries’ state-of-the-art new training facility which opens soon.Kelly Somers meets Bournemouth head coach Andoni Iraola and fomer captain Simon Francis, now first-team technical director, for a tour of the Cherries’ state-of-the-art new training…

Read More

Big Movers: Moderna Rose, Palantir, and Applovin Fell

Investors speculated on Covid vaccine firms. Despite the seasonal strength for flu-related vaccines ending, Moderna (MRNA) gained 11.65% to close at $47.53. Pfizer (PFE), BioNTech (BNTX), Arcturus Therapeutics (ARCT), and Novavax (NVAX) rallied. The Centers for Disease Control and Prevention announced respiratory illness data in the last week. Covid infections are more frequent alongside a…

Read More

Unifirst Jump on Q1 Numbers

UniFirst Corporation (NYSE: UNF) shares sprang up Wednesday, after releasing results for its first quarter ended November 30, 2024 as compared to the corresponding period in the prior fiscal year: The Wilmington, Mass.-based company reported consolidated revenues for the first quarter increased 1.9% to $604.9 million; operating income was $55.5 million, an increase of 4.5%….

Read More

IGC Gains on Word of Alzheimer’s Treatment

IGC Pharma, Inc. (NYSE:IGC) shares made small progress Wednesday, on word its ongoing Phase 2 trial for agitation in Alzheimer’s disease has been officially named CALMA (Calming Agitation in Alzheimer’s). The Potomac, Md.-based company says its trial’s new identity reflects its mission to address agitation, a syndrome affecting up to 76% of the 55 million…

Read More